US Patent 7868026 Therapeutic compounds
Patent 7868026 was granted and assigned to Pfizer Limited on January, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+71 characters)
Article
Patent abstract
The present invention provides compounds of formula (I),
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07868026 Therapeutic compounds US Patent 7868026 Therapeutic compounds
Infobox
Patent Number
0786802600
Patent Number
786802600
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
078680260
Date of Patent
January 11, 2011
0Patent Application Number
116214100
Date Filed
January 9, 2007
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
078680260
Date of Patent
January 11, 2011
0Patent Application Number
116214100
Date Filed
January 9, 2007
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07868026 Therapeutic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07868026
Date of patent
January 11, 2011
Patent application number
11621410
Date Filed
January 9, 2007
Patent primary examiner
Find more entities like US Patent 7868026 Therapeutic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
